<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Epigenetic Inactivation of Protocadherin 10 by Methylation in Colorectal Cancer</title>
    <FirstPage>472</FirstPage>
    <LastPage>477</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sahar</FirstName>
        <LastName>Tavakolian</LastName>
        <affiliation locale="en_US">Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.AND Department of Biology, University of Sistan and Balouchestan, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Matineh</FirstName>
        <LastName>Barati Bagherabad</LastName>
        <affiliation locale="en_US">Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AND 3 Department of Biology, Ashkezar Branch, Islamic Azad University, Ashkezar, Yazd, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Dor Mohammad</FirstName>
        <LastName>Kordi-Tamandani</LastName>
        <affiliation locale="en_US">Department of Biology, University of Sistan and Balouchestan, Zahedan, Iran. AND Genetics and Biotechnology Research Institute, University of Sistan and Baluchestan, Zahedan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Abbaszadegan</LastName>
        <affiliation locale="en_US">Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AND Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. AND  Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran .</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Amin</FirstName>
        <LastName>Kerachian</LastName>
        <affiliation locale="en_US">Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AND Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. AND Cancer Genetics Research Unit, Reza Radiotherapy and Oncology Center, Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>22</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Aberrant promoter methylation of CpG islands of tumor-suppressor genes has been recognized as one of the important tumor markers for cancer detection. The aim of this study was to investigate the promoter methylation status of protocadherin 10 (PCDH10), a tumor suppressor gene, in Iranian colorectal cancer (CRC) patients. Cancerous and the adjacent normal tissues obtained from 38 CRC patients were used to assess the methylation status of PCDH10 with Methylation Specific PCR, in addition, to study the expression level of this gene by quantitative PCR. The relationship between hypermethylation and the demographic characteristics of these patients was analyzed. The promoter methylation level of PCDH10 was statistically different between tumoral and normal tissues in CRC patients. Twenty-seven out of 38 patients showed hypermethylation with a sensitivity of 73% and a specificity of 97%. PCDH10 expression decreased in 15 cases (46%) as 16 cases (50 %) showed overexpression and 1 case (4%) had no changes. Not a significant association was reported between PCDH10 hypermethylation and the clinicopathological characteristics (P&gt;0.05). Our results indicated that PCDH10 methylation has a critical function in CRC, with a nearly elevated sensitivity and a high specificity in the Iranian population, qualify it as a potential candidate biomarker.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7640</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7640/5300</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evolution and Comparison Effects of Fludrocortisone and Betamethasone on Glucose and Lipid Profile in Rats</title>
    <FirstPage>478</FirstPage>
    <LastPage>483</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Jamshidi</LastName>
        <affiliation locale="en_US">Department of Toxicology-Pharmacology, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. AND Pharmaceuitical Sciences Research Center, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Naeem</FirstName>
        <LastName>Malmir</LastName>
        <affiliation locale="en_US">School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Hyperglycemia may associate with improper use of glucocorticoids, impaired insulin function, or both, and is associated with many complications such as hyperlipidemia and Hyperglycemia. Researches suggest that proper use of glucocorticoids can delay the onset and progression of complications of hyperglycemia and hyperlipidemia. In the present study, we compare two of these compounds on glucose and lipid profile level. We use 40 male Wistar rats from the Yazd Animal infertility center. Initially, the rats were randomly divided into 2 groups, and then each group was divided into 4 groups. Subsequently, fludrocortisone doses of 12, 24 and 36 mg/kg were administered to rats, and dosages of 6, 12 and 18 mg/kg for betamethasone administered to rats on a daily basis at 1 o'clock for 21 days by intraperitoneal injection. Betamethasone and Fludrocortisone increased blood glucose and AST, ALT, TG, LDL, VLDL, and decreased HDL, causing red pigmentation in the skin, and obesity and puffiness of the rats. In all of the measured factors, fludrocortisone changes were more than betamethasone. Fludrocortisone and betamethasone also had significant effects on weight, which was more pronounced with fludrocortisone. As the dose increased, the levels of AST, ALT, and cholesterol, TG, VLDL and LDL in the blood increased significantly and HDL levels decreased more in the blood, but fludrocortisone showed a stronger effect than betamethasone. Therefore, it can be expected that the use of Betamethasone would be logical due to fewer side effects than fludrocortisone.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7849</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7849/5301</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis</title>
    <FirstPage>484</FirstPage>
    <LastPage>491</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shadi</FirstName>
        <LastName>Ghourchian</LastName>
        <affiliation locale="en_US">Deprtment of Neurology, School of Medicine, University of Maryland, Baltimore, MD, USA.</affiliation>
      </Author>
      <Author>
        <FirstName>Nazanin</FirstName>
        <LastName>Mahinparvar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehri</FirstName>
        <LastName>Salari</LastName>
        <affiliation locale="en_US">Deprtment of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Yalda</FirstName>
        <LastName>Nikanpour</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahin</FirstName>
        <LastName>Sanaei</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Akbari</LastName>
        <affiliation locale="en_US">Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>09</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">This study aimed to compare the efficacy of rituximab versus Cyclophosphamide on active secondary progressive multiple sclerosis (SPMS). The randomized clinical trial was performed from 2015 to 2017 in multiple sclerosis (MS) clinics affiliated to Isfahan MS society (IMSS). Patients were randomized to two groups, and one of them received Rituximab that was repeated every six months in case of medical indication. The other one received a monthly pulse of methylprednisolone plus cyclophosphamide (Endoxan, Baxter, UK) until two years. Expanded disabilities status scale (EDSS), clinical, and MRI findings were assessed every six months. Statistical analysis was performed using SPSS software. 39 patients in the Rituximab group and 30 in the Cyclophosphamide group with similar age and gender distribution were entered for analysis. At baseline, the mean number of attacks in the Rituximab group was significantly more than the Cyclophosphamide group (P=0.0001). After 6, 12, and 18 months of treatment, the rate of attacks was similar between groups although it increased significantly in the Rituximab group (P=0.030) after 24 months of treatment. EDSS was increased in the Rituximab group more than the other group at the end of the study. Both drugs were well-tolerated by patients. The EDSS was increased in the Rituximab group but the disability score did not worsen in the Cyclophosphamide group. Both therapies were associated with a reduction in disease attacks and improvement in radiologic findings in a two-year period of follow-up.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/8096</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/8096/5302</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Rhythmic Breath Holding and Its Effect on Arterial Blood Pressure and Its Correlation With Blood Gases</title>
    <FirstPage>492</FirstPage>
    <LastPage>498</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Bharti</FirstName>
        <LastName>Bhandari</LastName>
        <affiliation locale="en_US">Department of Physiology, Government Institute of Medical Sciences, Greater Noida, Uttar Pradesh, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Manisha</FirstName>
        <LastName>Mavai</LastName>
        <affiliation locale="en_US">Department of Physiology, Govt. Medical College, Bharatpur, Rajasthan, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Yogendra</FirstName>
        <LastName>Singh</LastName>
        <affiliation locale="en_US">Department of Physiology, All India Institute of Medical Sciences, Raebarelli, Uttar Pradesh, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Bharati</FirstName>
        <LastName>Mehta</LastName>
        <affiliation locale="en_US">Department of Physiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Omlata</FirstName>
        <LastName>Bhagat</LastName>
        <affiliation locale="en_US">Department of Physiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>01</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>05</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">A single episode of breath-holding (BH) is known to elevate the blood pressure, and regular breathing exercise lowers the blood pressure. This prompted us to investigate how a series of BH epochs would affect the cardiovascular system. To observe arterial blood pressure (ABP) and heart rate (HR) changes associated with a series of &#x201C;BH epochs&#x201D; following maximum inspiration and maximum expiration and find the underlying mechanisms for the change by autonomic activity. Thirty-five healthy young adults were instructed to hold their breath repetitively, for 5 minutes, in two patterns, one following maximum inspiration and other following maximum expiration. ABP and ECG (for Heart Rate Variability) were continuously recorded at rest and during both the maneuvers. Capillary blood gases (BG) were zanalyzed at baseline and at the breakpoint of the last epoch of BH. ABP rose significantly at the breakpoint during both the maneuvers. No change in HR was observed. There was significant fall in PO2 from 94.7 (4.1) mmHg at baseline to 79.1 (9.0) mmHg during inspiratory and 76.90 (12.1) mmHg during expiratory BH. Similarly, SPO2 decreased from 96.3 (1.9) % at baseline to 95.4 (1.5) % and 94.5 (2.7) % during inspiratory and expiratory BH, respectively. Rise in PCO2 from 39.5(3.1) mmHg at baseline to 42.9 (2.7) mmHg and 42.1 (2.8) mmHg during inspiratory and expiratory BH respectively was observed. There was no significant correlation between blood gases and arterial blood pressure. Among HRV parameters, a significant decrease in SDNN, RMSSD, HFnu, total power and SD1/SD2 and the significant increase in LFnu, LF/HF and SD2 were observed during both BH patterns. Rhythmic BH patterns affect the cardiovascular system in similar way as a single episode of BH. Sympathetic overactivity could be the postulated mechanism for the same.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7687</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7687/5303</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Relationship Between Serum Iron Profile and Liver Density in Non-Enhanced CT-Scan</title>
    <FirstPage>499</FirstPage>
    <LastPage>502</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Aziz-Ahari</LastName>
        <affiliation locale="en_US">Department of Radiology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Khaleghi</LastName>
        <affiliation locale="en_US">Department of Radiology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Farahani</LastName>
        <affiliation locale="en_US">Department of Radiology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kaveh</FirstName>
        <LastName>Samimi</LastName>
        <affiliation locale="en_US">Department of Radiology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>01</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">It is known that liver biopsy is the gold standard of diagnosing liver iron deposition. By considering liver biopsy complication and cost, introducing a method to restrict unnecessary biopsy or even an alternative for liver biopsy can be useful. This study examined the relationship between serum iron profile and liver density on CT-Scan without contrast material injection. In this study, 76 patients were referred from different Rasoul-Akram Hospital parts in 2015-2016 (People who have undergone abdominal CT-scan for any reason, and blood tests included iron and lipid profiles). To calculate the liver mean density of a CT-scan, densities of 12 sites with an individual area of 1 cm2 on 3 different sections of the liver were obtained, and their average was recorded. Data were analyzed by SPSS V.16 using Kolmogorov-Smirnov,&#xA0; independent T-test, and two-sample T-tests with a significance level of P&lt;0.05. There is a significant relationship between the serum iron and serum ferritin levels with liver density. By increasing TIBC levels, the difference between liver and spleen densities increases, but no significant correlation was found between TIBC level and liver density. Moreover, there was no relationship between serum iron levels and serum ferritin with the difference between liver and spleen densities. The evaluation of liver density may be an alternative to liver biopsy in some cases or at least can be considered to restrict unnecessary biopsies.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7707</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7707/5304</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Comparative Study of Clinical and Paraclinical Findings of Elderly and Non-Elderly Patients With Acute Pneumonia and Pneumosepsis</title>
    <FirstPage>503</FirstPage>
    <LastPage>509</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad Mahdi</FirstName>
        <LastName>Majzoobi</LastName>
        <affiliation locale="en_US">Department of Infectious Diseases, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. AND Brucellosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran .AND Sina Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Jalalvand</LastName>
        <affiliation locale="en_US">Department of Infectious Diseases, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Khanlarzadeh</LastName>
        <affiliation locale="en_US">Department of Community Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Moradi</LastName>
        <affiliation locale="en_US">Department of Community Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>02</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Accurate diagnosis and timely treatment of pneumonia, as one of the most common infectious diseases in elderly patients, require careful attention to the clinical and paraclinical findings, which may be different between the elderly and non-elderly patients. The aim of the present study was to compare the clinical, laboratory, and radiological findings of elderly and non-elderly patients with pneumonia and pneumosepsis. This cross-sectional study was performed on 97 elderly and 93 non-elderly patients with pneumonia, admitted to Sina hospital in Hamadan, west of Iran, in 2017. Patients in both groups were also compared in terms of the underlying diseases, sepsis rate, electrolyte disturbances and CURB-65 criteria. All underlying diseases, except for HIV infection, in addition to clinical findings such as tachypnea, lethargy, decreased consciousness, hypotension, and respiratory alkalosis were significantly more common in the elderly, compared to the non-elderly group. In the elderly group, the average length of hospital stay, sepsis rate, and mortality rate were 9.4 days, 74.2%, and 21.7%, respectively versus 6.2 days, 46.3%, and 3.2%, respectively in the non-elderly group. Patients in the two groups were significantly different in terms of CkkURB-65 criteria and radiological findings. For the timely diagnosis of pneumonia and pneumosepsis in the elderly, it is necessary to consider any alteration in respiratory rate and consciousness status. Also, for proper treatment, the clinicians should pay attention to the existence of any comorbidities and electrolyte disturbances.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7749</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7749/5305</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Relationship Between Distribution of Human Resources Distribution and Performance Indicators of Hospitals Before and After Implementation of Health System Evolution Plan in Iran</title>
    <FirstPage>510</FirstPage>
    <LastPage>517</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Dargahi</LastName>
        <affiliation locale="en_US">Department of Management Sciences and Health Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. AND Health Information Management Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Golsa</FirstName>
        <LastName>Shaham</LastName>
        <affiliation locale="en_US">Department of Health Care Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>09</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The implementation of the Health System Evolution Plan has resulted in an increase in the rate of patient&#x2019;s referral to hospitals of medical universities, and thus, hospitals&#x2019; performance indicators. The aim of the present study is to investigate the changes in hospital indicators after the implementation of the Health System Evolution Plan and the relationship between this plan and distribution of human resources in hospitals of Tehran University of Medical Sciences. This was a descriptive-analytical and cross-sectional study. The research population consisted of information about human resources and performance indicators before and after the implementation of the Health System Evolution Plan in the hospitals. The research tool was a data collection form. The collected data were analyzed in SPSS software, and analytical results were obtained using the Pearson correlation test and Two Sample t-test. The results showed that there was a significant relationship between hospitals performance indicators and the distribution of human resources after the implementation of the Health System Evolution Plan. In fact, this plan has increased the deficit of nursing and paraclinical staff. In addition, the results showed as hospitals&#x2019; performance indicators have increased, more human resources has been recruited in these hospitals. The success of Implementation of Health System Evolution Plan and development of general hospitals indicators need comprehensive. Planning for retainment of all groups of health workers and paying attention to appropriate distribution of physicians, nurses, and paraclinical staff in public hospitals and finally a comprehensive review of human resources standards by the Iranian Ministry of Health.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/8108</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/8108/5306</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Heterozygous STXBP1 Gene de novo Mutation in an Iranian Child With Epileptic Encephalopathy: Case Report</title>
    <FirstPage>508</FirstPage>
    <LastPage>521</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Heidari</LastName>
        <affiliation locale="en_US">Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Soleyman-Nejad</LastName>
        <affiliation locale="en_US">Ariagene Medical Genetics Laboratory, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Taskhiri</LastName>
        <affiliation locale="en_US">Ariagene Medical Genetics Laboratory, Qom, Iran. AND Department of Molecular Biology, Islamic Azad University of Qom, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Isazadeh</LastName>
        <affiliation locale="en_US">Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Manzar</FirstName>
        <LastName>Bolhassan</LastName>
        <affiliation locale="en_US">Ariagene Medical Genetics Laboratory, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Shahpouri</LastName>
        <affiliation locale="en_US">Pediatric Clinical Research of Development Center, Qom University of Medical Sciences, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansour</FirstName>
        <LastName>Heidari</LastName>
        <affiliation locale="en_US">Ariagene Medical Genetics Laboratory, Qom, Iran. AND Department of Molecular Biology, Islamic Azad University of Qom, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Sadighi</LastName>
        <affiliation locale="en_US">Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>08</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The Syntaxin Binding Protein 1 (STXBP1) plays an important role in regulating neurotransmitter release and synaptic vesicle fusion through binding to syntaxin-1A (STX1A) and changing its conformation. In this study, we identified a de novo mutation (c.C1162T: p.R388X) in exon 14 of the STXBP1 gene causing an epileptic encephalopathy, early infantile, non-epileptic movement, and unclassified infantile spasms disorders in a 5-year-old boy by whole-exome sequencing. The segregation of this genetic variant was examined in the patient as well as in his parents. We found the R388X in heterozygous state in the proband but not in his parents. This genetic change could be due to de nova mutation or germlinemosaicism.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/8047</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/8047/5307</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Rare De Novo Robertsonian Translocation t(21q; 21q) in an Iranian Child With Down Syndrome: A Case Report</title>
    <FirstPage>522</FirstPage>
    <LastPage>524</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Nikfar</LastName>
        <affiliation locale="en_US">Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran. AND Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. AND Imam Khomeini Genetic Counseling Center, Welfare Organization of Zanjan, Zanjan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojdeh</FirstName>
        <LastName>Mansouri</LastName>
        <affiliation locale="en_US">2 Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gita</FirstName>
        <LastName>Fatemi Abhari</LastName>
        <affiliation locale="en_US">Imam Khomeini Genetic Counseling Center, Welfare Organization of Zanjan, Zanjan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>08</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>09</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Down syndrome or trisomy 21 is the most common genetic disorder with a prevalence of 1 in 700 live-born infants. It is characterized by the intellectual disability of varying range, developmental delay, distinctive facial features and various physical abnormalities. The most frequent clinical features include hypotonia, short stature, short neck, upward slanting eyes, &#xFB02;at nasal bridge, bulging tongue, small ears and a single palmar crease of the hands. Mainly there are three cytogenetic forms of Down syndrome including free trisomy 21, mosaicism and Robertsonian translocation. We describe the case of a 1-year-old Iranian female child who presented to our genetic counseling center with intellectual and physical disabilities. The most common features of Down syndrome were present. The cytogenetic analysis confirmed the diagnosis, with detection of the Robertsonian translocation t(21q; 21q). The patient's parents were found to be both phenotypically and cytogenetically normal, so the identified Robertsonian translocation t(21q; 21q) probably have arisen de novo.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/8050</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/8050/5308</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Ectopic Partial Intrahepatic Gallbladder: Magnetic Resonance Imaging and Clinical Findings</title>
    <FirstPage>525</FirstPage>
    <LastPage>527</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ozkan</FirstName>
        <LastName>Ozen</LastName>
        <affiliation locale="en_US">Department of Radiology, School of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Mani</FirstName>
        <LastName>Habibi</LastName>
        <affiliation locale="en_US">Department of General Surgery, Alanya Education and Research Hospital, Alanya Alaaddin Keykubat University, Antalya, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Yavuz</FirstName>
        <LastName>Yuksel</LastName>
        <affiliation locale="en_US">Department of Radiology, School of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>01</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Ectopic gallbladder (GB) is a very rare anomaly. Ectopic GB can be found in intrahepatic, suprahepatic, retrohepatic, retroperitoneal sites as well as in falciform ligament, intra-abdominal wall, left abdominal quadrant and intrathoracic localizations. A 43-year-old male patient presented with a right upper quadrant pain in the abdomen. Upon detection of a cystic lesion with lobulated contour associated with GB in the liver in ultrasound examination, dynamic magnetic resonance imaging (MRI), MRI cholangiopancreatography, and contrast-enhanced MRI cholangiography were performed on the patient. MRI revealed that the lesion was a partial ectopic intrahepatic GB. In this article, we presented an ectopic partial intrahepatic gall bladder anomaly, which is very uncommon and has been previously described by surgical operations and cadaver studies, according to our literature review.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7719</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7719/5313</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Are Iranians Aware of Carbon Monoxide Poisoning: Symptoms and Its Prevention Strategies?</title>
    <FirstPage>528</FirstPage>
    <LastPage>528</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Seyed Hassan</FirstName>
        <LastName>Emami-Razavi</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahsa</FirstName>
        <LastName>Ghajarzadeh</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sepehr</FirstName>
        <LastName>Aziz</LastName>
        <affiliation locale="en_US">School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amirhossein</FirstName>
        <LastName>Givan</LastName>
        <affiliation locale="en_US">School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>S. Adeleh</FirstName>
        <LastName>Mirjafari</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Faezeh</FirstName>
        <LastName>Sodagari</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/8326</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/8326/5311</pdf_url>
  </Article>
</Articles>
